Fertility‐sparing approach to malignant ovarian germ cell tumors – Oncologic and obstetric outocome: A retrospective study

医学 未成熟畸胎瘤 生殖细胞肿瘤 回顾性队列研究 无性细胞瘤 保持生育能力 畸胎瘤 妇科 不育 生育率 化疗 怀孕 外科 人口 内科学 卵巢 环境卫生 生物 遗传学
作者
Ali̇ Ayhan,Mehmet Tunç,Hüseyin Akıllı,Nihan Haberal,Alı Haberal
出处
期刊:International journal of gynaecology and obstetrics [Wiley]
卷期号:164 (3): 1074-1079 被引量:4
标识
DOI:10.1002/ijgo.15141
摘要

Abstract Objective To evaluate oncologic (such as disease‐free and overall survival) and obstetric outcomes in patients diagnosed with malignant ovarian germ cell tumors (MOGCTs). Methods Patients diagnosed with MOGCTs between March 2007 and February 2022 were evaluated and patients who underwent fertility sparing surgery were included in this retrospective study. The obstetric and oncologic outcomes were evaluated by collecting data up until the patient's last follow‐up visit from the hospital records and patient files. The study was approved by Başkent University Institutional Review Board (KA23/124). Results Seventy FSS patients were included in this study. The median age of the patients was 22.5 years (range: 11–37). The median follow‐up time was 92.0 months (10–189). Immature teratoma was the most common histological subtype (32.9%). Bilateral involvement was detected in only one patient with immature teratoma (1.4%). The 5‐year DFS rates of immature teratoma, dysgerminoma, yolk sac, and mixed germ cell histologic types were 91.1%, 94.1%, 82.4%, and 88.9%, respectively ( P : 0.716). The 5‐year OS rates of the same histologic types were 95.7%, 100%, 88.2%, and 88.9%, respectively ( P = 0.487). All patients (100%) had a regular menstrual cycle after the completion of adjuvant treatment. The mean time between the last chemotherapy and menstruation was 4.38 months. To date, a total of 34 patients tried to conceive after the completion of disease treatment. A total of 23 (67.6%) patients conceived, resulting in 27 live births in 22 (100%) patients. Conclusion Fertility preservation should be the first treatment option in MOGCTs in young patients due to the unilateral involvement of the disease and its chemosensitive nature.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
ZZzz完成签到,获得积分10
刚刚
1秒前
斯文败类的应助被ding采纳,获得30
3秒前
wz完成签到,获得积分10
3秒前
3秒前
天青妖发布了新的文献求助10
3秒前
4秒前
4秒前
MST发布了新的文献求助10
4秒前
4秒前
5秒前
斯文败类的应助被蛋堡采纳,获得10
5秒前
陌路发布了新的文献求助10
5秒前
泥嚎完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
momo完成签到 ,获得积分10
6秒前
苦雨完成签到,获得积分10
6秒前
大尾巴鱼完成签到,获得积分10
6秒前
yoooo完成签到,获得积分10
6秒前
7秒前
7秒前
fyj完成签到,获得积分10
8秒前
ygd完成签到,获得积分10
8秒前
whalefall发布了新的文献求助10
8秒前
jiaokaige发布了新的文献求助10
9秒前
充电宝的应助被yixuanshi采纳,获得10
9秒前
蒋xiao发布了新的文献求助10
9秒前
9秒前
霁月发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
11秒前
霁月发布了新的文献求助10
11秒前
11秒前
11秒前
隐形曼青的应助被兰先生采纳,获得10
12秒前
李开心发布了新的文献求助10
12秒前
研友_VZG7GZ的应助被dit采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187652
求助须知:如何正确求助?哪些是违规求助? 9575758
关于积分的说明 21842805
捐赠科研通 7785538
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559480
邀请新用户注册赠送积分活动 2481963